Youwei Bi
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Advanced Breast Cancer Therapies
- Lung Cancer Treatments and Mutations
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Oncology 7
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Yaning Wang (6 shared papers)Richard Pazdur (9 shared papers)Banu A. Karimi-Shah (2 shared papers)Dinko Rekić (2 shared papers)Badrul A. Chowdhury (2 shared papers)Julia A. Beaver (4 shared papers)Harpreet Singh (4 shared papers)Atiqur Rahman (2 shared papers)
- Journals
- Clinical Cancer Research (7 papers)The Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (3 papers)The AAPS Journal (3 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Youwei Bi
24 papers receiving 805 citations
Youwei Bi's Hit Papers
Peers
Comparison fields: 5 of 84
- Pulmonary and Respiratory Medicine 275
- Oncology 232
- Cancer Research 75
- Genetics 47
- Pharmacology 38
Countries citing papers authored by Youwei Bi
This map shows the geographic impact of Youwei Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youwei Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youwei Bi more than expected).
Fields of papers citing papers by Youwei Bi
This network shows the impact of papers produced by Youwei Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youwei Bi. The network helps show where Youwei Bi may publish in the future.
Co-authors
The 25 scholars most cited alongside Youwei Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC Hit paper breakdown → | 2021 | 202 |
| 2 | 2017 | 128 | |
| 3 | 2018 | 90 | |
| 4 | 2019 | 43 | |
| 5 | 2015 | 43 | |
| 6 | 2019 | 40 | |
| 7 | 2022 | 38 | |
| 8 | 2023 | 37 | |
| 9 | 2019 | 35 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 22 | |
| 12 | 2022 | 21 | |
| 13 | 2021 | 18 | |
| 14 | 2018 | 15 | |
| 15 | 2012 | 14 | |
| 16 | 2023 | 12 | |
| 17 | 2021 | 9 | |
| 18 | 2018 | 8 | |
| 19 | 2020 | 6 | |
| 20 | 2024 | 4 |
About Youwei Bi
Youwei Bi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pediatrics, Perinatology and Child Health, Pharmacology and Surgery, having authored 28 papers that have together received 815 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (6 papers), HER2/EGFR in Cancer Research (3 papers), Statistical Methods in Clinical Trials (3 papers), Lung Cancer Treatments and Mutations (3 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (275 citations), Oncology (232 citations), Cancer Research (75 citations), Genetics (47 citations) and Pharmacology (38 citations). Youwei Bi has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Yaning Wang, Richard Pazdur, Banu A. Karimi-Shah, Dinko Rekić, Badrul A. Chowdhury, Julia A. Beaver, Harpreet Singh, Atiqur Rahman, Pallavi S. Mishra‐Kalyani and Nicole Drezner. Their work appears in journals such as Clinical Cancer Research, The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, The AAPS Journal and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.